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4) certainantioxidants, especiallyphenolic
ones, repress AP-1 transactivation;
and 5) as a net effect antioxidantsinhibitNF-icB transactivation. DAG, diacylglycerol; RPTK, receptor-associated protein tyrosine kinases; ROS, reactive oxygen species; TCF, ternarycomplex factor; SRF, serum response factor; SRE, serum response element; TRE, tetradecanoylphorbolacetate (TPA) response eletnent.
NF-KB: A REL FAMILY TRANSCRIPTIONAL ACTIVATION

Rel proteins
The eukaryotic transcription factor NF-KB is a member of the Rd family of proteins that are present in the cytosol in an inactive form. The Rel protein family comprises two groups classified on the basis of their structure, funcion, and mode of synthesis.
Group Dimerization is functionally important because it is required for DNA binding of the activated factor (4, 5) .
1KB
In the dormant form, two types of Rel protein complexes are found in the cytosol: 1) a Rel homo-or heterodimer (e.g., pSO-p65) bound to a member of the 1KB family of inhibitor proteins, and 2) a complex between a mature Rel group II protein (e.g., p65) and a group I precursor (4, 5) .
Clinical implications of NF-KB
One major clinical significance of NF-KB activation is that it is involved in human immunodeficiency virus (HIV) gene expression.
The long terminal repeat of HIV-1 has been shown to contain two NF-KB binding sites that may be crucial in regulating AIDS latency (6) . Baur et al. (7) reported a dose-dependent inhibitory effect of the natural thiol antioxidant a-lipoate on HIV-l replication. We were interested in the possible mode of action of a-lipoate on HIV-1 and observed that ct-lipoate inhibits NF-KB activation in response to a variety of stimuli in Jurkat human T cells (Fig. 2) .
NF-KB may also play a role in atherogenesis, because minimally modified human low-density lipoproteins (LDL) result in activation of NF-KB (8). NF-KB can also be activated in response to an atherogenic diet (9) (12) . Some other target genes that are regulated by NF-KB activity include those that affect acute inflammation responses, cytokine production, and nitric oxide synthase expression (4) . Effective strategies to inhibit NF-KB activation should be of therapeutic importance. 
ROS AS INDUCERS
Which form of ROS activates NF-KB?
Hydrogen peroxide has been found to be effective in activating DNA binding of NF-KB in vivo but not in vitro (18) . Such an observation suggests that a by-product of hydrogen peroxide in an in vivo situation probably is responsible for the NF-KB binding. Cells overexpressing antioxidant enzymes with a well-defined activity for ROS removal are a valuable tool to test the specific form of ROS that are involved in triggering the activation of NF-icB. In our laboratory, transient catalase (H202 -HO) overexpression studies with cos-1 cells have shown that hydrogen peroxide may not serve as a messenger for TNF-a or phorbol ester induced NF-KB activation (19 TPA is a remarkable activator of protein kinase C and other agents that lead to protein kinase C activation such as serum and growth hormones. cFos proteins and mRNA have shorter half-lives than cJun proteins and mRNA. As a result, before induction most of the AP-1 complex is present in the form of Jun homoand heterodimers.
After induction, Fos proteins are expressed and most of the induced AP-i are Fos-Jun heterodimers.
The differential regulation of the c-fos and c-jun genes supports the contention that the function of cFos induction is to generate an initial spike of transcriptional activation, whereas ciun is responsible for a steady sustained AP-i activity. The cis-acting element that mediates cFos expression in response to activation by serum, certain growth factors, UV irradiation, and TPA is a 20 bp dyad symmetry or serum response element (SRE) located in the c-fos promoter. A 67 kDa transcription factor serum response factor (SRF) is phosphorylated and binds to the SRE as a homodimer.
This DNA binding of SRF is enhanced by the physical interaction of a phosphorylated 62 kDa ternary complex factor (TCF) protein that binds to a second DNA binding site adjacent to SRE. ciun expression is driven by the binding of preexisting AP-1 proteins to a TRE in the c-jun promoter (Fig. 1) . For a description of AP-1 and its mode of action, see ref
Clinical implications of AP-1
A collapse of the regulatory mechanisms that govern normal growth and development is manifested as neoplasia. Insights into the molecular basis of such events have been gained through the biochemical and genetic study of protooncogenes, the progenitors of retroviral transforming genes. Apart from being implicated in tumor promotion, AP-1 activation is involved in disorders of the nervous system. Most neuronal tissues express basal levels of AP-1, which increase dramatically in response to certain stimuli.
Electric stimulation or drug-induced seizure induces AP-i activation in the hippocampus, which in turn enhances growth factor mRNA expression. 
Involvement of ROS in AP-! activation induced by various other stimuli
Recently it was shown that growth factor-induced AP-1 activation is also ROS dependent. TNF-a and basic fibroblast growth factor induced ROS production, which acted as a common signal to stimulate c-fos gene expression (70). Angiotensin
Il-induced AP-1 DNA binding and proliferative hypertrophic responses in skeletal musclederived cells are ROS mediated (71) . Mitogenic stimulation is also known to induce oxidative stress. After 30-60 mm of such stimulation, a buildup of intracellular ROS has been detected (72) . Scavengers of the most dangerous form of ROS, the OH, inhibited lymphocyte mitogenesis (73). Mitogen-induced AP-1 activation has been observed to be antioxidant inhibitable and has thus been suggested to be ROS mediated (74) . ROS is also involved in the activation of AP-i by ionizing radiation (75) . Oxidative stress caused by ionizing radiation and hydrogen peroxide challenge was a potent inducer of c-jun expression. This effect was observed to be protein kinase C dependent and was evident in both normal and tumor human cells (69) .
How do ROS activate AP-1?
Not much is known about the exact mechanisms underlying ROS-dependent AP-i activation. Perturbation of cellular thiol redox status has been suggested to be a signal that may be implicated in the induction of c-fos and c-jun expression caused by asbestos-induced oxidative stress (76) . In support of this, high intracellular glutathione disulfide has been shown to be implicated in AP-i activation (54 
